Barbie, D. A., Xie, M., Broggi, M., Cheng, Y., Spigel, D. R., Cho, B. C., Fang, J., Chen, Y., Zenke, Y., Lee, K. H., Wang, Q., Navarro, A., Buchmeier, E. L., Özgüroğlu, M., Hann, C. L., Chen, J., Lai, W. V., Shrestha, Y., Senan, S. (2025). Clinical and molecular characteristics of early progressors (EPs) and long-term progression-free survivors (LTPs) from the phase 3 ADRIATIC trial of consolidation durvalumab (D) vs placebo (P) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8014